Journal
NANO LETTERS
Volume 18, Issue 11, Pages 6655-6659Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.8b02340
Keywords
Nanomedicine; cancer immunotherapy; cancer vaccine; drug delivery; nanotechnology
Categories
Funding
- Mayo Clinic Center for Regenerative Medicine
- National Institute of Neurological Disorders and Stroke [R01 NS104315]
- Florida Center for Brain Tumor Research & Accelerate Brain Cancer Cure
- Cancer Prevention and Research Institute of Texas CPRIT [RR180017]
- National Natural Science Foundation of China [81572500]
- Hunan Young Talent [2016RS3036]
Ask authors/readers for more resources
Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
